Veterinary News and Research

RSS

TB germs' metabolic 'escape pathways' may be neutralized by new drugs to shorten duration of therapy

New research suggests the bacteria that cause tuberculosis alter their metabolism to combat exposure to antimicrobials, and that these metabolic "escape pathways" might be neutralized by new drugs to shorten the troublesome duration of therapy.

31 May 2017

First generic version of drug to treat ADHD receives FDA approval

The U.S. Food and Drug Administration today approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients.

30 May 2017

Scientists identify genetic risk factor for equine squamous cell carcinoma

Squamous cell carcinoma (SCC) is the most common cancer found in equine eyes and the second most common tumor of the horse overall. Thanks to a recent genetic study led by UC Davis, horse owners can now identify horses at risk for ocular SCC and make informed breeding decisions.

25 May 2017

FDA grants accelerated approval to cancer treatment based on common biomarker

The U.S. Food and Drug Administration today granted accelerated approval to a treatment for patients whose cancers have a specific genetic feature (biomarker).

23 May 2017

Researchers urge caution in treating injured young athletes with cell-based therapies

Physicians, parents and coaches should be cautious when considering treating injured young athletes with platelet rich plasma (PRP), stem cells or other types of regenerative medicine, says a nationally recognized sports medicine clinician and researcher at the University of Miami Miller School of Medicine and UHealth Sports Medicine Institute.

22 May 2017

FDA warns Americans about inaccurate lead testing in children and mothers

The U.S. Food and Drug Administration and Centers for Disease Control and Prevention are warning Americans that certain lead tests manufactured by Magellan Diagnostics may provide inaccurate results for some children and adults in the United States.

18 May 2017

FDA expands approval for cystic fibrosis drug to treat additional rare gene mutations

The U.S. Food and Drug Administration today expanded the approved use of Kalydeco (ivacaftor) for treating cystic fibrosis.

18 May 2017

Researchers identify new drug target for two common types of myeloid leukemia

University of Georgia researchers, with colleagues from the University of Tokyo, have identified a new drug target for the two most common types of myeloid leukemia, including a way to turn back the most aggressive form of the disease.

17 May 2017

Research using pig knees may improve treatment of joint injuries in young people

Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have published research on how the knees of pigs compare to human knees at various stages of maturity -- a finding that will advance research by this group and others on injury treatment in young people.

15 May 2017

Research networks focus on investigating spread of antimicrobial resistance in humans, animals

"Antimicrobial-resistant bacteria pose a complex challenge. This is why Germany, with its German Antimicrobial Resistance Strategy DART2020, is making sustained efforts to protect the health of humans and animals", says BfR President Professor Dr. Dr. Andreas Hensel.

12 May 2017

FDA approves use of new Flourish device to treat infants born with esophageal atresia

The U.S. Food and Drug Administration today authorized use of the Flourish Pediatric Esophageal Atresia Anastomosis, a first-of-its-kind medical device to treat infants up to one year old for a birth defect that causes a gap in their esophagus, called esophageal atresia.

12 May 2017

Family dog could help kids with disabilities incorporate more physical activity into daily lives

The family dog could serve as a partner and ally in efforts to help children with disabilities incorporate more physical activity into their daily lives, a new study from Oregon State University indicates.

10 May 2017

Study identifies conservation management activities that could affect Lyme disease risk

Lyme disease – an infection contracted from the bite of an infected tick– is an important emerging disease in the UK, and is increasing in incidence in people in the UK and large parts of Europe and North America.

10 May 2017

Transmission of mosquito-borne diseases may happen at lower temperatures than previously thought

Transmission of mosquito-borne diseases, such as Zika, occur at lower temperatures than previously thought, a recently released study co-authored by two University of South Florida researchers shows.

9 May 2017

FDA approves new treatment for people with ALS

The U.S. Food and Drug Administration today approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis, commonly referred to as Lou Gehrig's disease.

5 May 2017

FDA approves new drug and chemotherapy combination for treatment of adult patients with AML

The U.S. Food and Drug Administration today approved Rydapt (midostaurin) for the treatment of adult patients with newly diagnosed acute myeloid leukemia who have a specific genetic mutation called FLT3, in combination with chemotherapy.

28 Apr 2017

Study shows how antibiotic treatments may offset beneficial effects of whole grain intake

According to recommendations from the Danish Veterinary and Food Administration, adult Danes should consume at least 75 g whole meal a day.

28 Apr 2017

Stivarga receives expanded FDA approval for treatment of liver cancer

The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafinib) to include treatment of patients with hepatocellular carcinoma (HCC or liver cancer) who have been previously treated with the drug sorafenib.

28 Apr 2017

FDA approves first drug for treating rare form of Batten disease

The U.S. Food and Drug Administration today approved Brineura (cerliponase alfa) as a treatment for a specific form of Batten disease. Brineura is the first FDA-approved treatment to slow loss of walking ability in symptomatic pediatric patients 3 years of age and older with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase-1 (TPP1) deficiency.

27 Apr 2017

Researchers identify new antibiotic resistance gene in bacteria from dairy cows

Researchers of the University of Bern have identified a new antibiotic resistance gene in bacteria from dairy cows. This gene confers resistance to all beta-lactam antibiotics including the last generation of cephalosporins used against methicillin-resistant Staphylococcus aureus.

26 Apr 2017

Veterinary News and Research

TB germs' metabolic 'escape pathways' may be neutralized by new drugs to shorten duration of therapy

First generic version of drug to treat ADHD receives FDA approval

Scientists identify genetic risk factor for equine squamous cell carcinoma

FDA grants accelerated approval to cancer treatment based on common biomarker

Researchers urge caution in treating injured young athletes with cell-based therapies

FDA warns Americans about inaccurate lead testing in children and mothers

FDA expands approval for cystic fibrosis drug to treat additional rare gene mutations

Researchers identify new drug target for two common types of myeloid leukemia

Research using pig knees may improve treatment of joint injuries in young people

Research networks focus on investigating spread of antimicrobial resistance in humans, animals

FDA approves use of new Flourish device to treat infants born with esophageal atresia

Family dog could help kids with disabilities incorporate more physical activity into daily lives

Study identifies conservation management activities that could affect Lyme disease risk

Transmission of mosquito-borne diseases may happen at lower temperatures than previously thought

FDA approves new treatment for people with ALS

FDA approves new drug and chemotherapy combination for treatment of adult patients with AML

Study shows how antibiotic treatments may offset beneficial effects of whole grain intake

Stivarga receives expanded FDA approval for treatment of liver cancer

FDA approves first drug for treating rare form of Batten disease

Researchers identify new antibiotic resistance gene in bacteria from dairy cows

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News